{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T15:21:33Z","timestamp":1775229693930,"version":"3.50.1"},"reference-count":29,"publisher":"American Society for Microbiology","issue":"12","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"funder":[{"name":"National AIDS Control Organisation, India","award":["F.9(58)DSACS\/STI(AD)\/ NACP-III\/2009-10"],"award-info":[{"award-number":["F.9(58)DSACS\/STI(AD)\/ NACP-III\/2009-10"]}]},{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["5\/3\/3\/4\/2013-ECD-I, ECD\/ADHOC\/41\/2014-15"],"award-info":[{"award-number":["5\/3\/3\/4\/2013-ECD-I, ECD\/ADHOC\/41\/2014-15"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2016,12]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>\n            Antimicrobial susceptibility testing of 258\n            <jats:named-content xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" content-type=\"genus-species\" xlink:type=\"simple\">Neisseria gonorrhoeae<\/jats:named-content>\n            isolates by Etest determined that 60.1% were multidrug resistant (MDR), while 5% of the strains had decreased susceptibility to currently recommended extended-spectrum cephalosporins (ESCs). Among these, 84.5% of MDR strains and 76.9% of strains that had decreased susceptibility to ESCs were susceptible to gentamicin. No MDR isolate was resistant to gentamicin. These\n            <jats:italic>in vitro<\/jats:italic>\n            results suggest that gentamicin might be an effective treatment option for the MDR strains and in dual therapy for gonorrhea. However, further research regarding the clinical treatment outcomes is essential.\n          <\/jats:p>","DOI":"10.1128\/aac.01907-16","type":"journal-article","created":{"date-parts":[[2016,10,11]],"date-time":"2016-10-11T17:04:42Z","timestamp":1476205482000},"page":"7518-7521","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":17,"title":["Gentamicin Susceptibility among a Sample of Multidrug-Resistant Neisseria gonorrhoeae Isolates in India"],"prefix":"10.1128","volume":"60","author":[{"given":"Manju","family":"Bala","sequence":"first","affiliation":[{"name":"Apex Regional STD Teaching, Training &amp; Research Centre, Vardhman Mahavir Medical College &amp; Safdarjung Hospital, New Delhi, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vikram","family":"Singh","sequence":"additional","affiliation":[{"name":"Apex Regional STD Teaching, Training &amp; Research Centre, Vardhman Mahavir Medical College &amp; Safdarjung Hospital, New Delhi, India"},{"name":"Department of Life Sciences, SunRise University, Alwar, Rajasthan, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aradhana","family":"Bhargava","sequence":"additional","affiliation":[{"name":"Apex Regional STD Teaching, Training &amp; Research Centre, Vardhman Mahavir Medical College &amp; Safdarjung Hospital, New Delhi, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monika","family":"Kakran","sequence":"additional","affiliation":[{"name":"Apex Regional STD Teaching, Training &amp; Research Centre, Vardhman Mahavir Medical College &amp; Safdarjung Hospital, New Delhi, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naveen Chandra","family":"Joshi","sequence":"additional","affiliation":[{"name":"Apex Regional STD Teaching, Training &amp; Research Centre, Vardhman Mahavir Medical College &amp; Safdarjung Hospital, New Delhi, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ravi","family":"Bhatnagar","sequence":"additional","affiliation":[{"name":"Department of Life Sciences, SunRise University, Alwar, Rajasthan, India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dks188"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1097\/OLQ.0000000000000261"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1136\/sextrans-2013-051162"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1136\/sextrans-2012-050904"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.05760-11"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1586\/eri.09.63"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1097\/OLQ.0b013e31822e6361"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1097\/OLQ.0b013e3181bf575c"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.35.11.2985-2988.1997"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1186\/2046-4053-3-104"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciu521"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1136\/sextrans-2011-050362"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1136\/sti.77.3.218"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkq476"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1136\/sextrans-2013-051184.1138"},{"key":"e_1_3_2_17_2","unstructured":"Public Health Agency of Canada. 2014. National surveillance of antimicrobial susceptibilities of Neisseria gonorrhoeae\u2014annual summary 2014. http:\/\/healthycanadians.gc.ca\/publications\/drugs-products-medicaments-produits\/2014-neisseria\/index-eng.php."},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.5533\/DST-2177-8264-2015271-211"},{"key":"e_1_3_2_19_2","volume-title":"Laboratory diagnosis of sexually transmitted infections, including human immunodeficiency virus","author":"World Health Organization","year":"2013","unstructured":"World Health Organization. 2013. Laboratory diagnosis of sexually transmitted infections, including human immunodeficiency virus. World Health Organization, Geneva, Switzerland. http:\/\/www.who.int\/reproductivehealth\/publications\/rtis\/9789241505840\/en\/index.html."},{"key":"e_1_3_2_20_2","unstructured":"Bell SM Pham JN Fisher GT. 2009. Antibiotic susceptibility testing by the CDS method: a manual for medical and veterinary laboratories 5th ed p 42\u201358. http:\/\/web.med.unsw.edu.au\/cdstest."},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2012-000969"},{"key":"e_1_3_2_22_2","volume-title":"CLSI M100-S17","author":"Clinical and Laboratory Standards Institute","year":"2007","unstructured":"Clinical and Laboratory Standards Institute. 2007. Performance standards for antimicrobial susceptibility testing; 17th informational supplement. CLSI M100-S17. Clinical and Laboratory Standards Institute, Wayne, PA."},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkw102"},{"key":"e_1_3_2_24_2","first-page":"1","volume-title":"Global action plan to control the spread and impact of antimicrobial resistance in Neisseria gonorrhoeae","author":"World Health Organization","year":"2012","unstructured":"World Health Organization. 2012. Global action plan to control the spread and impact of antimicrobial resistance in Neisseria gonorrhoeae, p 1\u201336. Department of Reproductive Health and Research, World Health Organization, Geneva, Switzerland. http:\/\/www.who.int\/reproductivehealth\/publications\/rtis\/9789241503501\/en\/."},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1136\/sextrans-2012-050674"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00155-11"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.45.1.359-362.2001"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.38.11.2530"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.38.7.1688"},{"key":"e_1_3_2_30_2","unstructured":"Centers for Disease Control and Prevention (CDC). 2015. 2015 sexually transmitted diseases treatment guidelines: gonococcal infections. CDC Atlanta GA. www.cdc.gov\/std\/tg2015\/gonorrhea.htm."}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.01907-16","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.01907-16","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T20:30:26Z","timestamp":1645475426000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.01907-16"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":29,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["10.1128\/AAC.01907-16"],"URL":"https:\/\/doi.org\/10.1128\/aac.01907-16","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"2016-09-01","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2016-09-29","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2016-11-21","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}